Adverse events:Linking COX2 to cardiovascular side effects
Nature Reviews Drug Discovery 11,442 (2012).
doi:10.1038/nrd3766
Author:Charlotte Harrison
Anti-inflammatory inhibitors of cyclooxygenase 2 (COX2) have been shown to increase the risk of adverse cardiovascular events in clinical trials. This study showed that such adverse events could be due to COX2-induced suppression of prostaglandin I2 (PGI2) synthesis;PGI2
Nature Reviews Drug Discovery –Issue –nature.com science feeds












































